Madrigal Pharmaceuticals, Inc. Financials

Market Capitalization $6.64 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	-13.65
Forward PE	-21.41
Price to Sales TTM	$20.91
Price to Book MRQ	$9.33
Enterprise to Revenue	18.89
Enterprise to EBITDA	-14.15

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	-123.38%
Operating Margin	-57.79%
Return on Assets TTM	-25.56%
Return on Equity TTM	-50.16%

Income Statement

Revenue TTM	$317,383,008
Revenue per Share TTM	$14.56
Quarterly Revenue Growth	32.84%
Gross Profit TTM	$306,636,992
EBITDA	$-423,841,984
Net Income to Common TTM	$-391,588,992
Diluted EPS TTM	$-17.84
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	$843,068,032
Total Cash per Share MRQ	$37.97
Total Debt MRQ	$
Total Debt to Equity MRQ	16.85
Current Ratio MRQ	5.91
Book Value per Share MRQ	$32.03

Cash Flow

Operating Cash Flow TTM	$-395,305,984
Levered Free Cash Flow TTM	$-274,112,384

MDGL Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	22,004,679
Float Shares	10,955,099
Avg 10 Volume	309,590
Avg 30 Volume	None
Shares Short	4,152,509
Short Ratio	13.32
Short % of Shares	21.68%
% Held by Insiders	7.73%
% Held by Institutions	108.21%

Stock Price Summary

Beta	-1.08
Fifty Two Week Low	$200.63
Fifty Two Week High	$377.46
Fifty Two Week Change	7.47%
Day 50 MA	$293.39
Day 200 MA	$297.84

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date	2016-07-25
Ex Dividend Date
Last Split Factor
Last Split Date	2016-07-25